FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/063677 [Registered on: 06/03/2024] Trial Registered Prospectively
Last Modified On: 29/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective 
Study Design  Other 
Public Title of Study   A study to assess the Arterial blood to expired carbon dioxide difference to predict mortality and morbidity in patients with sepsis. 
Scientific Title of Study   Arterial To End Tidal Carbon dioxide Difference As A Predictor Of Mortality And Morbidity In Patients With Sepsis - A Prospective Observational Study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Version 1.0 dated 30/07/2022  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Radhika K T 
Designation  DrNB Critical Care Medicine Resident  
Affiliation  Narayana Health City 
Address  Mazumdar Shaw Medical Centre, Medical Intensive Care Unit, 2nd Floor, Narayana Health City, Bommasandra, Bengaluru

Bangalore
KARNATAKA
560099
India 
Phone  6363604104  
Fax    
Email  radhikadivakaran92@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Arjun Alva 
Designation  Consultant, Critical Care Medicine 
Affiliation  Narayana Health City 
Address  Mazumdar Shaw Medical Centre, Medical Intensive Care Unit, 2nd Floor, Narayana Health City, Bommasandra, Bengaluru.

Bangalore
KARNATAKA
560099
India 
Phone  9108026001  
Fax    
Email  arjun.alva.dr@narayanahealth.org  
 
Details of Contact Person
Public Query
 
Name  Dr Radhika K T 
Designation  DrNB Critical Care Medicine Resident  
Affiliation  Narayana Health City 
Address  Mazumdar Shaw Medical Centre, Medical Intensive Care Unit, 2nd Floor, Narayana Health City, Bommasandra, Bengaluru

Bangalore
KARNATAKA
560099
India 
Phone  6363604104  
Fax    
Email  radhikadivakaran92@gmail.com  
 
Source of Monetary or Material Support  
Narayana Health City, 258/A Bommasandra Industrial area, Hosur Road, Bengaluru, 560099  
 
Primary Sponsor  
Name  Dr Radhika K T 
Address  Narayana Health City, 258/A Bommasandra Industrial area, Hosur Road, Bengaluru, 560099  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Radhika K T  Medical Intensive Care Unit   Mazumdar Shaw Building, Medical Intensive Care Unit, 2nd Floor, Narayana Health City, 258/A Bommasandra Industrial area, Hosur Road, Bengaluru, 560099
Bangalore
KARNATAKA 
6363604104

radhikadivakaran92@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Narayana Health Academic Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: A419||Sepsis, unspecified organism,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Aged above 18 years
2.Clinically suspected or proven sepsis with or without septic shock requiring invasive ventilator support. 
 
ExclusionCriteria 
Details  1. Chronic obstructive pulmonary disease
2. Interstitial lung disease
3. Bronchial asthma
4. Obstructive sleep apnoea
5. Cardiogenic shock
6. More than 7 days since the suspicion of sepsis
7. Post cardiac arrest resuscitated patients
8. Pregnancy
9. Pulmonary embolism
10. Patients requiring all non invasive methods of ventilatory support 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Arterial to end tidal carbon dioxide difference as a marker of in-hospital mortality in patients with suspected or proven sepsis.   28 days from the day of admission. 
 
Secondary Outcome  
Outcome  TimePoints 
Arterial to end tidal carbon dioxide difference as a marker of morbidity in patients with suspected sepsis in terms of
-No of days of hospital stay
-No of days of ICU stay
-No of days of ventilatory support
-Need for vasoactive support; average dose per day and duration
-Requirement of renal replacement therapy  
28 days from the day of admission 
Correlation between Arterial to end tidal carbon dioxide difference and SOFA Score as well as Capillary refill time.  28 days from the day of admission 
 
Target Sample Size   Total Sample Size="110"
Sample Size from India="110" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Sepsis is life-threatening multi-organ dysfunction caused by a dysregulated immune response to an infectious cause. Sepsis and septic shock are major healthcare problems, affecting millions of people around the world. Early recognition and appropriate management in the initial phases of sepsis improve outcomes.

The difference between arterial carbon dioxide tension (PaCO2) and ETCO2 is shown to correlate with the physiologic dead space (VD/VT), which is normally 3–5 mmHg in healthy adults. Higher value of arterial to end tidal CO2 difference has been found to predict worse outcomes in trauma and respiratory distress patients. Sepsis can be associated with myocardial depression and changes in total peripheral vascular resistance , Acute respiratory distress syndrome (ARDS) and respiratory failure irrespective of aetiology of sepsis. Septic encephalopathy, with its associated reduction in respiratory drive, appears outcomes. Thus reduced cardiac output, diminished respiratory drive, impaired alveolar ventilation with arteriovenous shunting and/or sepsis related ARDS may act in isolation or together manifesting  as an increased arteriolar- end tidal CO2  gap and thus predict

reduced survival and increased need for intensive care support in patients with sepsis

In this study we intend to evaluate arterial to end tidal carbon dioxide difference as predictor of mortality and morbidity in patients with suspected sepsis. We also extend our study to find the correlation between arteriolar - end tidal CO2 gap and already established prognostic markers of sepsis like Lactate level, capillary refill time and Sequential Organ Failure Assessment Score (SOFA).

 
Close